# Exposure to selenomethionine causes selenocysteine misincorporation and protein aggregation in Saccharomyces cerevisiae.

Pierre Plateau, Cosmin Saveanu, Roxane Lestini, Marc Dauplais, Laurence Decourty, Alain Jacquier, Sylvain Blanquet, Myriam Lazard

<figure><img src="image_1.png" /></figure>

## To cite this version:

Pierre Plateau, Cosmin Saveanu, Roxane Lestini, Marc Dauplais, Laurence Decourty, et al.. Exposure to selenomethionine causes selenocysteine misincorporation and protein aggregation in Saccharomyces cerevisiae.. Scientific Reports, 2017, 7, pp.44761. 10.1038/srep44761. pasteur-01496769

HAL Id: pasteur-01496769

https://pasteur.hal.science/pasteur-01496769

Submitted on 27 Mar 2017

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>
SCIENTIFIC REPORTS

<figure><img src="image_3.png" /></figure>

OPEN

# Exposure to selenomethionine causes selenocysteine misincorporation and protein aggregation in *Saccharomyces cerevisiae*

Pierre Plateau<fnref n="1" />, Cosmin Saveanu², Roxane Lestini³, Marc Dauplais<fnref n="1" />, Laurence Decourty², Alain Jacquier², Sylvain Blanquet<fnref n="1" /> & Myriam Lazard<fnref n="1" />

Selenomethionine, a dietary supplement with beneficial health effects, becomes toxic if taken in excess. To gain insight into the mechanisms of action of selenomethionine, we screened a collection of ≈5900 *Saccharomyces cerevisiae* mutants for sensitivity or resistance to growth-limiting amounts of the compound. Genes involved in protein degradation and synthesis were enriched in the obtained datasets, suggesting that selenomethionine causes a proteotoxic stress. We demonstrate that selenomethionine induces an accumulation of protein aggregates by a mechanism that requires *de novo* protein synthesis. Reduction of translation rates was accompanied by a decrease of protein aggregation and of selenomethionine toxicity. Protein aggregation was supressed in a Δ*cys3* mutant unable to synthetize selenocysteine, suggesting that aggregation results from the metabolization of selenomethionine to selenocysteine followed by translational incorporation in the place of cysteine. In support of this mechanism, we were able to detect random substitutions of cysteinyl residues by selenocysteine in a reporter protein. Our results reveal a novel mechanism of toxicity that may have implications in higher eukaryotes.

Selenium is an essential micronutrient for many living species, including humans. It is translationally incorpo- rated as selenocysteine (SeCys) into a few proteins, some of which are antioxidant enzymes, protecting cells from harmful oxidative damage<fnref n="1" />. Incorporation of SeCys occurs via a specific mechanism that recodes a UGA codon from its normal translation termination function². However, at higher doses, many selenium compounds act as pro-oxidants, generating reactive oxygen species (ROS) that induce cytotoxicity and cellular apoptosis³. Since the discovery of the first selenoprotein glutathione peroxidase, in 1973⁴, selenium has attracted considerable scientific interest, especially with respect to its potential use as a nutritional supplement in the prevention and treatment of several diseases, including cancer⁵,⁶. In spite of extensive studies the mechanisms of action and cellular targets of selenium compounds are still unclear. As adverse health effects have recently been associated with excessive dietary selenium supplementation, a comprehensive understanding of the molecular basis of selenium toxicity is becoming an important public health issue⁷⁻⁹.

Selenium effects depend on its chemical speciation¹⁰. For example, selenolates (RSe) are redox active com- pounds that have cytotoxic pro-oxidant properties³. Seleno-amino acids such as selenomethionine (SeMet) and selenocysteine¹¹,¹² can be translationally misincorporated in proteins in place of methionine and cysteine, respec- tively, leading to abnormal and potentially toxic products. Thus, the pathways underlying the biological activity of the different seleno-compounds can be very different and a better understanding of their modes of action is necessary.

Received: 13 December 2016

Accepted: 13 February 2017

Published: 17 March 2017

<footnote n="1">¹Laboratoire de Biochimie, Ecole Polytechnique, CNRS UMR7654, 91128 Palaiseau Cedex, France. ²Institut Pasteur, Unité de Génétique des Interactions Macromoléculaires, CNRS-UMR3525, Paris, France. ³Laboratoire d'Optique et Biosciences, Ecole Polytechnique, CNRS UMR7645-INSERM U1182 91128, Palaiseau Cedex, France. Correspondence and requests for materials should be addressed to M.L. (email: myriam.lazard@polytechnique.edu)</footnote>
Hydrogen selenide, produced by the reduction of inorganic selenium salts (selenate, selenite), is believed to exert a key role in the toxicity as well as in the anticarcinogenic properties of selenium¹³. It reacts with dioxygen and thiols, resulting in the generation of ROS that induce oxidative stress, DNA damage and, ultimately, cell death¹⁴. Genomic studies using *Saccharomyces cerevisiae* have highlighted the importance of DNA repair pathways in protecting yeast cells against inorganic selenium toxicity. Indeed, many mutants of genes involved in homologous recombination and DNA damage checkpoint showed hypersensitivity to selenide¹⁵ or selenite¹⁶,¹⁷ suggesting that DNA double-strand breaks are a dominant cause of toxicity.

Large-scale approaches in *S. cerevisiae* were also used to study SeMet toxicity. Seitomer *et al*.¹⁶ showed that tolerance to SeMet treatment was largely unaffected by the loss of most of the genes involved in DNA damage and oxidative stress pathways, suggesting that SeMet toxicity involves mechanisms distinct from those of inorganic selenium. Bockhorn *et al*.¹⁸ showed that deletion of the *CYS3* gene encoding cystathionine γ-lyase resulted in increased resistance to SeMet. We recently showed that several mutants hypersensitive to H₂Se display wild-type sensitivity to SeMet, and that *SOD1* deletion imparts sensitivity against SeMet but not against selenide¹⁹. Furthermore, we found that SeMet toxicity was mediated by the transsulfuration pathway amino acids selenohomocysteine and/or selenocysteine, with the involvement of superoxide production. However, the origin of the toxicity of these metabolites remained unknown. To address this question, we have screened the systematic collection of *S. cerevisiae* haploid knockout strains, previously used to determine biological processes involved in sensitivity to sodium selenide¹⁵, to analyze the effects of loss of function on growth in the presence of SeMet. This analysis showed the importance of protein degradation pathways to protect cells against SeMet damages. Mass spectrometry analysis and fluorescence microscopy revealed SeCys incorporation in a reporter polypeptide and protein aggregation in yeast cells exposed to SeMet. Our results suggest that SeMet toxicity results from its metabolization into SeCys followed by random incorporation in the place of cysteine, which in turn promotes protein aggregation.

## Results

**Identification of deletion mutants involved in sensitivity or resistance to SeMet.** To identify cellular targets of SeMet in *S. cerevisiae*, we screened a collection of ≈4900 isogenic haploid non-essential deletion mutants and ≈1000 haploid DAmP (Decreased Abundance by mRNA Perturbation) mutants of essential genes, by growth in liquid culture of pooled bar-coded mutants. Yeast cells were grown for 10 generations in Synthetic Complete (SC) medium supplemented with 100 µM L-methionine and L-cysteine, in the absence or presence of L-SeMet. SeMet was added at concentrations (12 and 20 µM) that decreased the growth rate of the parental strain (BY4741) by 15 and 25%, respectively. The tags were amplified, and hybridized to barcode specific Agilent microarrays. The hybridization data were used to calculate relative growth values (relative fitness score) for each mutant in the population. The results from three independent experiments and the average value of these results are presented in Supplementary Table S1. As shown in Supplementary Figure 1, the average value obtained for the two SeMet concentrations were highly correlated (r = 0.88). Therefore, only the 20 µM SeMet dataset was used for further analysis. Supplementary Figure 2 shows the distribution of relative fitness scores for each mutant in this dataset.

A total of 157 mutants (out of 5241 for which at least 2 independent results were obtained, 3%) displayed a growth defect in the presence of SeMet associated to a relative fitness score lower than −1.5 and were defined as SeMet-sensitive strains. The 283 mutants that had a fitness score >1.5 were classified as SeMet-resistant strains. g:Profiler (biit.cs.ut.ee/gprofiler) was used to associate Gene Ontology (GO) terms with the sensitive and resistant datasets (Fig. 1). GO terms related to protein metabolic processes were significantly enriched in both datasets (see Fig. 1a and b and Table 1 for significant genes). Genes related to ubiquitin-mediated protein degradation, either via the proteasome complex or via the multivesicular body sorting pathway, were over-represented among deletion mutants sensitive to SeMet (Fig. 1a). Notably, the six essential ATPases of the proteasome regulatory particle (RPT1 to RPT6 genes), necessary for unfolding of cytoplasmic proteins targeted for degradation, are among the most sensitive DAmP mutants. 10 out of the 13 genes coding for the ESCRT complexes, which are involved in recognition and vacuolar targeting of misfolded proteins destined for proteolysis²⁰, are present in the sensitive dataset. In addition, this set also contains three subunits of the co-chaperone prefoldin complex involved in the folding of non-native polypeptides²¹.

At the other end of the scale, mutants impaired in the translational process, including ribosomal subunits, proteins necessary for ribosome biogenesis and several tRNA-modifying enzymes represent around 50% of the SeMet-resistant dataset (see Fig. 1b and Table 1 for significant genes). This set also contains several subunits of the Lsm-Pat1 complex, involved in the regulation of mRNA turnover, and transcription factors, among which subunits of the RNA polymerase II mediator and SAGA complexes. These results indicate that SeMet tolerance involves mechanisms related to the folding or removal of damaged proteins, and that resistance to SeMet can be improved by slowing down protein biosynthesis. Both higher sensitivity and resistance of mutant strains point to protein homeostasis as a major actor in SeMet toxicity.

As expected from previous studies, genes involved in sulfur metabolism were found in both datasets (Table 1). In particular, our screen confirmed the resistant phenotype already observed for mutants of S-adenosylmethionine synthases (*sam1*, *sam2*)²², methionine permease (*mup1*)²³ and cystathionine γ-lyase (*cys3*)¹⁸. A role of superoxide radicals in SeMet toxicity was also confirmed by the sensitive phenotype of the *sod1* and *sod2* mutants¹⁹.

To determine whether SeMet and H₂Se toxicity share similar mechanisms, we searched for functional categories that were significantly enriched (p-value < 0.001) in the SeMet- (this study) and the H₂Se-sensitive subsets¹⁵. As shown in Fig. 1c, there was little overlap between biological processes required for SeMet and H₂Se tolerance. This analysis strengthens the idea that the mechanistic bases of selenium effects depend on the specific chemical form.
<figure><img src="image_4.png" /><figcaption>**Figure 1.** GO term analysis of the SeMet-sensitive and -resistant datasets. (a) Distribution of SeMet-sensitive mutants according to biological processes affected (upper panel). Hierarchical graph of GO terms enrichment relative to the genome (lower panel). (b) Distribution of SeMet-resistant mutants according to biological processes affected (upper panel). Hierarchical graph of GO terms enrichment relative to the genome (lower panel). The color indicates the p-value of the enrichment according to g:Profiler (yellow: $10^{-1}-10^{-3}$, orange: $10^{-3}-10^{-6}$, light red: $10^{-6}-10^{-10}$, dark red: $<10^{-10}$). (c) Functional categories significantly enriched (p < 0.001, fold enrichment >2) in the SeMet- or H₂Se-sentitive datasets. Only genes for which fitness scores were available in both screens were taken in consideration (137 and 135 genes in the SeMet and H₂Se datasets, respectively). The color indicates the fold enrichment for each category. Blank boxes indicate an enrichment <2.</figcaption></figure>

**Individual validation of selected mutants.** The genomic screen was performed in the BY4741 strain with a mutation in *MET17*, the gene that encodes O-acetyl homoserine sulphydrylase, the enzyme responsible for incorporating inorganic sulfur into the amino acid homocysteine. To ascertain that this mutation did not alter SeMet effects, several sensitive or resistant strains, chosen to represent the different pathways affected, were selected for individual analysis in the BY4742 background in which the sulfur assimilation pathway is functional. Genes deleted in the sensitive mutants *ubp6*, *ubp14* and *mub1* are involved in protein degradation; *LEU3* codes for a transcription factor that regulates genes involved in leucine biosynthesis; *TSA1* and *SOD1* are involved in redox homeostasis; *SRN2*, *VPS36* and *DID4* code for components of the ESCRT complexes involved in the sorting of proteins into the endosome. Genes deleted in the resistant mutants *uba4* and *urm1* are involved in tRNA
<table><caption>Table 1. List of sensitive and resistant genes and associated GO terms.</caption><thead><tr><th colspan="2">Significant SeMet sensitive mutants and associated GO terms</th></tr></thead><tbody><tr><td colspan="2"><strong>Ubiquitin-dependent protein catabolic process</strong></td></tr><tr><td>UBP6, UBP14, RPT1, RPT2, RPT3, RPT4, RPT5, RPT6, DOA1, UBR2, HRT1, MUB1</td><td></td></tr><tr><td>- via the multivesicular body sorting pathway</td><td></td></tr><tr><td>STP22, DOA4, GGA2, VPS25, DID4, VPS24, SNF7, SRN2, VPS36, VPS20, SNF8, BRO1</td><td></td></tr><tr><td><strong>Endosome membrane</strong></td><td></td></tr><tr><td>ATG15, VPS4, VPS27, VPS38, DID2</td><td></td></tr><tr><td><strong>Superoxide metabolic process</strong></td><td></td></tr><tr><td>SOD1, SOD2</td><td></td></tr><tr><td><strong>Sulfur compound metabolic process</strong></td><td></td></tr><tr><td>MET13, ADE3, GSH2</td><td></td></tr><tr><td><strong>Prefoldin complex</strong></td><td></td></tr><tr><td>PAC10, GIM5, YKE2</td><td></td></tr></tbody><thead><tr><th colspan="2">Significant SeMet resistant mutants and associated GO terms</th></tr></thead><tbody><tr><td><strong>tRNA processing</strong></td><td></td></tr><tr><td>TRM1, LOS1, MOD5, STP1, CGI121, PUS7</td><td></td></tr><tr><td>- tRNA wobble uridine modification</td><td></td></tr><tr><td>ELP2, ELP4, ELP6, NCS2, NCS6, UBA4, URM1, IKI3</td><td></td></tr><tr><td><strong>Ribosome biogenesis</strong></td><td></td></tr><tr><td>ECM1, SYO1, ARX1, RPA14, LOC1, CGR1, DBP3, SPT4, SLX9, TIF4631, PIH1, LRP1, RTC3, RPA34, MRT4, LTV1, FYV7, BUD20, HCR1, TSR2, TMA23, JJJ1, RPA49, NOP12, BUD21, PUS7, SRP40</td><td></td></tr><tr><td><strong>Ribosome</strong></td><td></td></tr><tr><td>RPL4A, RPS14A, RPP1A, RPL13A, RPP1B, RPP2B, RPS17B, RPL27B, RPL37B, RPL34A, RPS24A, RPL29, RPL24A, RPL7A, RPL28, RPL9A, RPS25A, RPL26B, RPL11B, RPL24B, RPS0A, RPL8A, RPL16A, RPL17B, RPL14A, RPS21A, RPL8B, RPS0B, RPL22A, RPL37A, RPS28B, RPS29A, RPL31B, RPS1A, RPL6B, RPS17A, RPS1B, RPL13B, RPL36A, RPS10B, RPL9B, RPL16B, RPS19B, RPS19A, RPS7A, RPL33B, RPL21B</td><td></td></tr><tr><td><strong>Sulfur compound metabolic process</strong></td><td></td></tr><tr><td>SAM1, SAM2, MUP1, CYS3, MET12, MET31</td><td></td></tr><tr><td><strong>Lsm1-7-Pat1 complex</strong></td><td></td></tr><tr><td>LSM1, LSM6, LSM7, PAT1</td><td></td></tr><tr><td><strong>Regulation of transcription</strong></td><td></td></tr><tr><td>- RNA polymerase II mediator complex</td><td></td></tr><tr><td>MED2, SSN2, SSN3, SSN8, GAL11, PGD1</td><td></td></tr><tr><td>- SAGA complex</td><td></td></tr><tr><td>GCN5, NGG1, ADA2, SGF29, CHD1</td><td></td></tr></tbody></table>

modifications and RPL26B and RPL29 code for ribosomal proteins. We measured growth rates of individual strains in the absence or presence of 20 µM SeMet and calculated fitness scores relative to the parental strain. Supplementary Figure 3 shows the average fitness score of individual strains grown in complete medium supporting fast growth (SC + methionine medium) or in a medium in which only auxotrophic requirements are supplied (SD + methionine medium) resulting in a reduced growth rate. In complete medium, all the mutants displayed the phenotype already observed in the genomic screen. This analysis also showed that the growth of several deletion strains, in particular the mutants of ESCRT I and II complexes and ribosomal proteins, was only weakly affected in SD medium, indicating that the effects of SeMet were more pronounced in rapidly growing cells.

**Exposure to SeMet causes protein aggregation.** Because genes involved in protein synthesis or degradation featured prominently in the set of sensitive and resistant mutants, we suspected that SeMet induced a proteotoxic stress. To confirm this hypothesis, we used a chromosomally integrated Hsp104-GFP reporter construct. Hsp104p is a chaperone that acts on aggregated proteins and promotes disaggregation and refolding²⁴. Upon heat shock, Hsp104p is induced and accumulates at the periphery of protein aggregates, which can thus be visualized as intense cytosolic fluorescent Hsp104-GFP containing foci. First, we questioned the capacity of SeMet to induce a heat-shock-like response and found that the expression of Hsp104-GFP, measured by fluorescence in crude extracts, was induced to similar levels upon exposure to 20 µM SeMet for 2 h or after a temperature shift to 42 °C (Fig. 2a). Then, the localization of Hsp104-GFP was monitored by fluorescence microscopy in cells exposed to increasing concentrations of SeMet (Fig. 2b). Hsp104-GFP distribution was diffuse in the cytoplasm of unexposed cells, whereas concentration-dependent aggregates formed in cells exposed to SeMet (Fig. 2c).
<figure><img src="image_5.png" /><figcaption>b</figcaption></figure>

<figure><img src="image_6.png" /><figcaption>c</figcaption></figure>

<figure><img src="image_7.png" /><figcaption>d</figcaption></figure>

<figure><img src="image_8.png" /><figcaption>**Figure 2.** SeMet promotes protein aggregation in vivo. (a) Induction of Hsp104-GFP by SeMet or heat shock. Exponentially growing BY4741-Hsp104-GFP cells were incubated in SC + 100 µM methionine for 2 h, either at 30°C in the presence of the indicated concentration of SeMet or at 42°C in the absence of SeMet. The fluorescence in whole cell extracts was recorded at 508 nm and normalized to the optical density of the extracts at 280 nm. The fluorescence of an extract from untagged BY4741 strain grown in SC + 100 µM methionine was subtracted from the results. The results are the mean ± S. D. of at least 3 experiments. (b) Hsp104-GFP localization was monitored by fluorescence microscopy (GFP) and differential interference contrast (DIC), in living BY4741-Hsp104-GFP cells after 1 h of exposure to various SeMet concentrations in SC + 100 µM methionine. Representative images obtained after maximum intensity z-projection, bar equals 10 µm.</figcaption></figure>

(c) Quantification of protein aggregation. The fraction of cells containing at least one Hsp104-GFP focus was determined by visual inspection of 300–600 cells in each condition. The results are the mean and range of at least 2 experiments. (d) Effect of cycloheximide (CHX) on protein aggregation induced by 1 h of exposure to 20 µM SeMet or heat shock at 42°C. BY4741-Hsp104-GFP cells grown in SC + 100 µM methionine were treated or not with 5 µg/ml cycloheximide for 1 h prior to the SeMet or heat-shock stress. Hsp104-GFP localization was monitored in living cells by fluorescence microscopy. Representative images obtained after maximum intensity z-projection, bar equals 10 µm.

At 12 µM SeMet, 80% of cells contained at least one distinct bright fluorescent focus. To determine whether SeMet-triggered protein aggregation required *de novo* protein synthesis, we treated cells with cycloheximide (5 µg/mL), to inhibit translation initiation, prior to the SeMet stress. As shown in Fig. 2d, cycloheximide prevented SeMet-induced aggregate formation, whereas it had little effect on the aggregation induced by a shift to 42°C, a condition that is known to induce thermal unfolding of native proteins. These results suggest that proteins in the process of synthesis/folding are likely to be prime targets of SeMet-induced aggregation.

Most of the null alleles strains displaying a SeMet-resistant phenotype are involved in the process of translation or regulation of translation. These deletion strains generally display growth rate defects²⁵. As shown in Fig. 3a, 80% of the SeMet-resistant mutants grew more slowly than the parental strain in the absence of stress, suggesting that a decreased growth rate provides an advantage under SeMet stress. Therefore, we checked whether slowing the rate of protein synthesis reduced SeMet-induced protein aggregation and toxicity. Low cycloheximide concentrations (0 to 100 ng/mL) were used to decrease cellular growth rate by 25, 45 and 65%. Reduction
<figure><img src="image_9.png" /><figcaption>**Figure 3.** Reduced growth rates affect SeMet toxicity and protein aggregation. (a) Relationship between SeMet resistance and growth in the absence of SeMet. Dots correspond to the growth fitness score in the absence of SeMet versus the relative fitness score in the presence of 20 µM SeMet, for strains resistant to SeMet (fitness score >1.5). (b) Effect of low cycloheximide concentrations on protein aggregation. Cycloheximide at the indicated concentrations was added to BY4741-Hsp104-GFP cells grown in SC + 100 µM methionine. After 1 h of incubation, 20 µM SeMet was added in the cultures and incubation was continued for 1 h. Hsp104-GFP localization was monitored in living cells by fluorescence microscopy. Representative images obtained after maximum intensity z-projection, bar equals 10 µm. (c) Generation times of BY4741 cells cultured in SC + 100 µM methionine at the indicated concentrations of cycloheximide in the absence (grey boxes) or presence (black boxes) of 20 µM SeMet. The results are the mean and range of at least 2 experiments. (d) Effect of reducing growth rates on SeMet toxicity and protein aggregation. The fraction of cells containing at least one Hsp104-GFP focus (●) was determined from the images in panel b, by visual inspection of 150–200 cells in each condition. SeMet growth inhibition (■) was calculated as the $log_2(T^{SeMet}/T^{cont})$ value where $T^{SeMet}$ and $T^{cont}$ are the generation times, calculated for each cycloheximide concentrations in panel c, in the presence and absence of SeMet, respectively. Values were plotted against the generation time in the absence of SeMet ($T^{cont}$). The results are the mean and range of at least 2 experiments.</figcaption></figure>

of translation rates was accompanied by a reduction of toxicity as well as number of cells containing aggregates (Fig. 3b,c,d), suggesting that protein aggregation is the cause of SeMet toxicity.

**Protein aggregation is dependent on SeCys synthesis.** Misincorporation of SeMet into proteins in place of methionine is not believed to induce major cytotoxicity²². By contrast, because SeCys is much more reactive than its sulfur-analogue, misincorporated SeCys is susceptible to form adducts with thiols or selenols generating misfolded aggregation-prone proteins. Therefore, we investigated protein aggregation in a Δcys3 mutant strain in which SeCys cannot be formed from SeMet. To support cell growth, this analysis was performed in the additional presence of 100 µM cysteine. In the absence of SeCys synthesis, Hsp104-GFP distribution remained diffuse in the cytoplasm up to 50 µM SeMet in the medium (Fig. 4), a SeMet concentration in which foci were detectable in 80% of wild-type cells. Direct exposure to SeCys (100 µM D,L-SeCys) induced aggregation in 35% of the cells in both strains. Upon heat shock, similar aggregate formation was observed in the Δcys3 and wild-type cells. These results, together with the requirement for CYS3 in SeMet toxicity, indicate that metabolization of SeMet to SeCys is necessary to generate protein aggregation and its associated toxicity.

**Selenoamino-acids incorporation in polypeptide chains.** Unspecific insertion of SeCys in proteins has already been observed in yeast cells grown in the presence of selenite¹². To determine whether SeCys can be incorporated into proteins when yeast cells are grown in the presence of SeMet, we used a strategy based on mass spectrometry. Yeast cells, expressing a tagged-version of Elongation Factor 1 (EF1-α), were grown in SC medium containing 20 µM SeMet and 100 µM methionine. EF1-α was chosen because it is a soluble medium size protein containing a significant number of cysteinyl residues and an equivalent number of methioninyl residues (7 and 8,
<figure><img src="image_10.png" /><figcaption>**Figure 4.** The presence of CYS3 is required for SeMet-induced protein aggregation. Hsp104-GFP localization in BY4741 and BY4741-Δcys3 cells after 1 h of exposure in SC + 100 µM methionine + 100 µM cysteine to 0, 20 µM and 50 µM SeMet, 100 µM D,L-SeCys in the presence of 1 mM TCEP or after 1 h heat shock at 42 °C was monitored in living cells by fluorescence microscopy. Representative images obtained after maximum intensity z-projection, bar equals 10 µm.</figcaption></figure>

respectively). After purification and proteolytic (Asp-N) digestion, the peptides were analyzed by LC-MS/MS and selenium substitution for sulfur was searched for and quantified. Protein sequence coverage was 86% with information for all of the sulfur-containing amino acids except the N-terminal methionine. Supplementary Figures 4, 5 and 6 show the ESI-MS/MS analyses and extracted ion chromatograms (XIC) of selected selenium-containing peptides (peptide 426–439 containing SeMet, peptides 110–117 and 360–370 containing SeCys). Table 2 summarizes the results of the mass spectrometric analysis. Insertion of a SeCys residue in replacement of cysteine was unambiguously identified at 3 positions (Cys111, Cys335, Cys361). The SeCys/Cys substitution ratio was 4.9 ± 3.5%. Selenium substitution for sulfur was found in 6 out of 7 methioninyl residues with an average Se/S substitution of 17.1 ± 5.3%, very close to the extracellular ratio of SeMet/Met.

Overall, these results suggest that SeMet-induced protein aggregation results from the metabolization of SeMet to SeCys and incorporation of SeCys in the place of cysteine in the course of translation.

## Discussion

Chemogenomic studies in yeast have been previously applied to hundreds of growth inhibitory chemicals with the aim of uncovering their mechanisms of action. These studies have helped to identify biological functions involved in the toxicity of several compounds including metals, pesticides and pharmaceutical drugs and have also proven useful to shed light on human diseases²⁶,²⁷. In this study, a *S. cerevisiae* deletion collection was employed to better understand the molecular mechanisms underlying SeMet toxicity. The spectacular enrichment of functions related to protein metabolic processes, including biosynthesis, folding and degradation, in both the sensitive and resistant datasets suggests that SeMet causes a proteotoxic stress. We searched the yeast fitness databases generated in large-scale studies by Giaever *et al.*²⁸ and Hoepfner *et al.*²⁹ for chemical genetic profiles with similarities to that of SeMet, potentially reflecting common biological targets or mode-of-action³⁰,³¹. Figure 5 shows a list of several stresses that share enriched GO terms with SeMet in both the sensitive and resistant datasets suggesting that all these stresses might affect protein functions. Indeed, exposure to elevated temperatures is known to destabilize protein structure and increase aggregation of improperly folded proteins. Several metals, including cadmium, cobalt and chromium, trigger oxidative protein damage and aggregation in yeast³²,³³. In addition, mRNA mistranslation due to sulfur starvation was shown to be a cause of hexavalent chromium toxicity³⁴,³⁵. Paraquat and 1-methyl-4-phenylpyridinium (MPP+) are environmental toxicants associated with an increased risk of developing Parkinson's disease, a neurodegenerative pathology characterized by an accumulation of insoluble protein deposits. Exposure of dopaminergic cells to paraquat or MPP+ was shown to decrease protein ubiquitination, leading to a dysfunction of protein degradation pathways³⁶. The molecular target of radicicol is the heat-shock protein Hsp90p, the inhibition of which affects protein quality control³⁷. Lastly, tunicamycin disrupts protein folding in the endoplasmic reticulum (ER) and activates the unfolded protein response³⁸.

In this study, we demonstrate that SeMet induces protein aggregation in a concentration-dependent manner by a mechanism that requires *de novo* protein synthesis. We observed a direct correlation between SeMet toxicity and protein aggregation. Slowing down translation, either by deletion of ribosomal protein genes or by using cycloheximide, improves SeMet resistance, suggesting that toxicity results from an impairment of cellular protein homeostasis that overwhelms cellular defenses against aggregated proteins. Reduction of the rate of translation elongation may improve the fidelity of translation and/or reduce the burden of the protein quality control machinery, both resulting in improved proteostasis³⁹. Because nearly complete replacement of methionine by SeMet is tolerated by yeast cells without measurable adverse effects²²,⁴⁰, it is unlikely that SeMet mistranslation causes massive aggregation. Several lines of evidence suggest that SeCys misincorporation in nascent proteins could be responsible for protein aggregation. Firstly, we recently showed that the toxicity of SeMet involved its metabolization to transsulfuration pathway amino acids¹⁹. Secondly, as observed earlier and again here, toxicity is
<table><caption>**Table 2. Ratio of Se/S substitution in EF1-α sulfur-containing peptides.** Cysteine-containing peptides are in light grey boxes. Sulfur-containing residues are in bold. *Peptides resulting from specific cleavage only at one terminus. aXIC peak areas for peptides 110–117 were above limit of detection (LOD) but lower than limit of quantification defined as LOQ = 3 X LOD.</caption><thead><tr><th>position</th><th>peptide sequence</th><th>modification</th><th>Mascot score</th><th>Se/S ratio (%)</th></tr></thead><tbody><tr><td>97-106</td><td>DFIKNMITGT*</td><td>SeMet<sub>102</sub></td><td>63</td><td>17.7</td></tr><tr><td>97-109</td><td>DFIKNMITGTSQA</td><td>SeMet<sub>102</sub></td><td>51</td><td>25.3</td></tr><tr><td>110-117</td><td>DCAILIIA*</td><td>SeCys<sub>111</sub></td><td>46</td><td>&lt; LOQ<sup>a</sup></td></tr><tr><td>147-155</td><td>QLIVAVNKM*</td><td>SeMet<sub>155</sub></td><td>43</td><td>14.1</td></tr><tr><td>148-155</td><td>LIVAVNKM*</td><td>SeMet<sub>155</sub></td><td>48</td><td>12.9</td></tr><tr><td>197-208</td><td>DNMIEATTNAPW*</td><td>SeMet<sub>199</sub></td><td>44</td><td>15.6</td></tr><tr><td>199-208</td><td>MIEATTNAPW*</td><td>SeMet<sub>199</sub></td><td>29</td><td>19.0</td></tr><tr><td>286-294</td><td>EVKSVEMHH</td><td>SeMet<sub>292</sub></td><td>50</td><td>10.4</td></tr><tr><td>286-297</td><td>EVKSVEMHHEQL</td><td>SeMet<sub>292</sub></td><td>34</td><td>20.2</td></tr><tr><td>330-341</td><td>DPPKGCASFNAT*</td><td>SeCys<sub>335</sub></td><td>51</td><td>2.8</td></tr><tr><td>360-367</td><td>DCHTAHIA*</td><td>SeCys<sub>361</sub></td><td>31</td><td>9.0</td></tr><tr><td>360-370</td><td>DCHTAHIACRF</td><td>SeCys<sub>361</sub></td><td>53</td><td>3.0</td></tr><tr><td>396-408</td><td>DAALVKFVPSKPM*</td><td>SeMet<sub>408</sub></td><td>51</td><td>8.8</td></tr><tr><td>426-437</td><td>DMRQTVAVGVIK*</td><td>SeMet<sub>427</sub></td><td>56</td><td>19.7</td></tr><tr><td>426-439</td><td>DMRQTVAVGVIKSV</td><td>SeMet<sub>427</sub></td><td>78</td><td>24.3</td></tr></tbody></table>

drastically reduced in a Δcys3 mutant. Concomitantly, protein aggregation is not observed in this mutant exposed to SeMet. In contrast, exposure to SeCys of wild-type as well as Δcys3 cells results in visible aggregation. Lastly, using cells grown in the presence of SeMet, we show that SeCys can be translationally incorporated in a reporter polypeptide. Random replacement of cysteine by the more reactive SeCys is likely to alter protein structure and induce misfolding by formation of non-native intermolecular or intramolecular selenylsulfide or diselenide bridges resulting in the formation of insoluble protein adducts. In addition, production of superoxide radicals during auto-oxidation of SeCys¹⁹ may also catalyze the oxidation of amino acid side chains⁴¹ contributing to aggregation of oxidized proteins. In particular, methioninyl residues are readily oxidized to methionine sulfoxide by ROS. Deletion of MXR2, one of the two genes encoding methionine sulfoxide reductase, results in a moderately sensitive phenotype (see Supplementary Table S1), suggesting that oxidation of methionine may contribute to SeMet toxicity. The hypersensitive phenotype of the sod1 and sod2 deletion mutants is also in agreement with an involvement of superoxides in the mechanism of protein aggregation.

To our knowledge, this is the first time that the molecular basis of SeMet toxicity is attributed to protein aggregation resulting from SeCys misincorporation. Examples of non-protein amino acids that can be incorporated into proteins and cause protein aggregation are already known. They include azetidine-2-carboxylic acid⁴², a proline analogue, or β-N-methylamino-L-alanine, the consumption of which has been associated with high incidence of amyotrophic lateral sclerosis⁴³. Translational errors inducing protein misfolding have been associated with several pathologies including neurodegeneration⁴⁴. For example, the mouse sticky mutation, which causes cerebellar Purkinje cell loss and ataxia, results from the substitution of serine for alanine due to a mutation in the editing domain of alanyl-tRNA synthetase⁴⁵.

The mechanism of SeMet toxicity evidenced here in yeast may be significant in other organisms. In higher plants, exposure to SeMet is not expected to result in SeCys misincorporation due to the absence of the pathway
<figure><img src="image_11.png" /><figcaption>**Figure 5.** Compounds sharing significantly enriched GO terms with SeMet simultaneously in the sensitive and resistant datasets. The 160 most sensitive, or 220 most resistant, genes corresponding to SeMet (this study), compounds n°3 (37 °C), 180 (CdCl₂), 181 (ZnCl₂), 182 (CoCl₂), 184 (K₂Cr₂O₇), 374 (Paraquat), 375 (MPP+) in ref. 28 and compounds n°828 (Radicicol), and 4177 (Tunicamycin) in ref. 29 were analyzed for simultaneous functional enrichment with the g:Profiler multiple gene lists tool (http://biit.cs.ut.ee/gprofiler/gcocoa.cgi). Only processes significantly enriched (p-value < 0.001) in the SeMet screen are represented. The number of genes annotated to the GO term in the input lists is indicated with a color code corresponding to the p-value of the enrichment. Abbreviations: BP, Biological process; CC, Cellular component.</figcaption></figure>

for conversion of methionine to cysteine. However, in plants exposed to inorganic selenium, the hypothesis that cysteine nonspecific replacement by SeCys partly accounts for selenium toxicity has already been discussed⁴⁶. In particular, Se-hyperaccumulator plants with high tolerance to selenium were shown to contain a SeCys methyl-transferase, which methylates SeCys and prevents its incorporation into proteins⁴⁷. Minimizing the misincorporation of SeCys by introduction of a SeCys methyltransferase gene has also been an effective strategy to increase Se tolerance in plants⁴⁸,⁴⁹. In addition, the ubiquitin-proteasome pathway, which we observe here to be important for SeMet tolerance in S. cerevisiae (Table 1), was recently implicated in SeCys toxicity in the plant Brassica napus⁵⁰. In cultured human cells, an increase of protein-bound selenium and the induction of an ER stress response were observed upon selenocystine treatment⁵¹, leading the authors to suggest that replacement of cysteine by SeCys in polypeptides triggered an accumulation of misfolded proteins. In this study, GO analysis did not reveal enrichment for components of the ER-associated protein degradation pathway or for ER-related unfolded protein response in the sensitive or resistant subsets. However, the similarity between the genetic profiles of SeMet and tunicamycin, a known ER stress inducer, indicates that SeMet may also induce an ER stress in yeast.

Our present work using yeast cells establishes that SeMet toxicity is mediated by protein aggregation. Down-regulation of protein synthesis rates improved resistance to SeMet. Reciprocally, fast growing cells were more sensitive to SeMet addition. Our findings bring new insights into the molecular mechanisms underlying selenoamino acids toxicity. They may help in designing protocols for clinical studies aiming to compare the health benefits versus negative consequences of supplementation with different forms of selenium⁵².

## Methods

**Strains and media.** The S. cerevisiae strains used in this study are derived from strain BY4742 (MATα his3Δ1 leu2Δ lys2Δ0 ura3Δ0) or BY4741 (MATa his3Δ1 leu2Δ met15Δ0 ura3Δ0). The parental strains and all the single mutants were obtained from Euroscarf. The BY4741 strain containing a GFP-tagged Hsp104 was purchased from ThermoFisher Scientific. GFP tagging of Hsp104 in yeast mutant strains was performed by PCR-mediated homologous recombination, and correct integrations were checked by PCR. Standard Synthetic Defined (SD) medium contained 0.67% (w/v) yeast nitrogen base (Difco), 2% (w/v) glucose and 50 mg/l of histidine, leucine, lysine and uracil and was buffered at pH 6.0 by the addition of 50 mM MES-NaOH. Standard Synthetic Complete (SC) medium contained 0.67% (w/v) yeast nitrogen base (Difco), 2% (w/v) glucose and 80 mg/l of adenine, uracil and all amino acids (160 mg/ml leucine) except methionine and cysteine and was buffered at pH 6.0 by the addition of 50 mM MES-NaOH. Media were supplemented in methionine and cysteine as indicated in the legends to the figures. All the amino acids were supplied as the L-enantiomers except SeCys which was the D,L-mixture. Because of its extreme sensitivity to oxidation, SeCys was prepared extemporaneously by reducing 2.5 mM selenocystine (Sigma) with 5 mM Tris (2-carboxyethyl) phosphine (TCEP) in 50 mM MES-NaOH, pH 6.0.
The pool of 4,885 S. cerevisiae mutants from the systematic deletion collection made in strain BY4741<sup>15,28</sup> was mixed with 979 barcoded DAmP strains of essential genes<sup>53</sup>. Pooled strains were pregrown for 5 generations in SC medium containing 100µM methionine and 100µM cysteine. Growth in the same medium supplemented with 0, 12 or 20µM SeMet was started at an OD<sub>650</sub> of 0.002. All three cultures were grown aerobically at 30°C, under shaking for 10 generations before harvesting cells.

For individual growth rate analysis, selected mutants were inoculated in the indicated medium supplemented with 0 or 20 µM SeMet at an OD<sub>650</sub> of 0.0025 and cell growth at 30 °C was monitored by measuring the OD<sub>650</sub> at various times during 24 h. The generation times were derived from the fit of experimental data to an exponential curve.

**Analysis of microarray data.** Microarray results were obtained using Agilent custom slides as described<sup>54</sup>. Briefly, DNA was extracted from pools of mutants at the start of the experiment (t = 0) and after growth (10 generations) in the presence or absence of SeMet, and barcode sequences were amplified with fluorescent-labelled oligonucleotides. Microarrays were scanned in a Genepix 4000B scanner (Molecular Devices) and the images were analyzed using GenePix Pro. The spot values were normalized using R scripts to report the relative fitness scores defined as the log<sub>2</sub>(treated/untreated) values. Relative growth fitness score of the mutant strains in the absence of SeMet was defined as the log<sub>2</sub>(untreated/t = 0) values.

**Fluorescence microscopy.** Yeast cells expressing Hsp104-GFP were grown at 30 °C to an OD<sub>650</sub> of 0.5 in SC medium supplemented with methionine and cysteine as indicated in the legends, followed by exposure to SeMet, to SeCys, or transfer to 42 °C, for 1 h. Where indicated, cells were treated with cycloheximide at the indicated concentration for 1 h prior to SeMet addition. Cells were mounted on glass slides covered with a thin layer of 1% agarose. Differential interference contrast (DIC; Nomarski interference contrast) and fluorescence images were obtained at room temperature using a ZEISS Axio Observer equipped with a 40×, 1.4 NA oil immersion objective. 470 nm excitation at maximum available intensity (4 W cm<sup>-2</sup>) and a filter set 65 HE (EX BP 475/30, BS FT 495, EM BP550/100) were used for fluorescence imaging. The lateral resolution was estimated to be 180 nm. Images were captured with digital camera AxioCam MRm. Z-stacks of 15 to 25 images with 260 nm spacing were recorded. Maximum intensity z-projections were performed with ImageJ and the images were analyzed manually.

**Fluorescence spectroscopy.** BY4741 cells expressing Hsp104-GFP (and a control untagged strain) were grown at 30 °C to an OD<sub>650</sub> of 0.5 in SC + 100 µM methionine, followed by 2 h exposure to 12.5 and 20 µM SeMet, or transfer to 42 °C. Whole cell extracts were prepared in 50 mM Tris-HCl (pH 7.5), 10 mM MgCl<sub>2</sub>, 250 mM NaCl, 5% (v/v) glycerol, 10 mM 2-mercaptoethanol (2-ME), by vortexing cells at 4 °C for 10 × 30 sec in the presence of an equal volume of glass beads (500–750 µm). After centrifugation at 10000 × g for 10 min, the supernatant was recovered and the optical density at 280 nm was determined. GFP fluorescence was recorded at 508 nm in a Jasco FP-8300 spectrofluorometer using an excitation wavelength of 487 nm (bandwidth 2.5 nm).

**Identification of sulfur substitution in EF1-α.** His-tagged EF1-α was purified and digested as described in Supplementary information. The nano LC-MS/MS analyses were performed as described<sup>55</sup>. Protein identification was performed using the Mascot database search engine (Matrix Science, London, UK) against the EF1-α-tag sequence (Supplementary Figure 4A) with semi-Asp-N Ambic specificity and 4 missed cleavages. Variable modifications included substitutions of cysteine and methionine by SeCys and SeMet, respectively, carbamidomethylation of cysteine and SeCys, oxidation of methionine and SeMet and conversion of SeCys to dehydroalanine. Peptide and fragment tolerance were respectively set at 10 ppm and 0.05 Da. Only peptides with Mascot ion scores above identity threshold (25) at less than 1% FDR (false discovery rate) were considered. MS extracted-ion chromatograms (XIC) of <sup>80</sup>Se and <sup>32</sup>S isotope peaks were generated using PeakView software (ABScieX). For relative quantification of peptides and selenized counterparts, incorporation rates were calculated as described<sup>12</sup>. Briefly, XIC peak areas were corrected by respective isotopic abundance and all forms described in variable modifications section were taken into account in the calculation of the substitution rates.

**References**

1. Hatfield, D. L., Tsuji, P. A., Carlson, B. A. & Gladyshev, V. N. Selenium and selenocysteine: roles in cancer, health, and development. *Trends Biochem. Sci.* **39**, 112–120 (2014).

2. Hatfield, D. L. & Gladyshev, V. N. How selenium has altered our understanding of the genetic code. *Mol. Cell. Biol.* **22**, 3565–3576 (2002).

3. Misra, S., Boylan, M., Selvam, A., Spallholz, J. E. & Bjornstedt, M. Redox-active selenium compounds—from toxicity and cell death to cancer treatment. *Nutrients* **7**, 3536–3556 (2015).

4. Flohe, L., Gunzler, W. A. & Schock, H. H. Glutathione peroxidase: a selenoenzyme. *FEBS Lett.* **32**, 132–134 (1973).

5. Rayman, M. P. Selenium in cancer prevention: a review of the evidence and mechanism of action. *Proc. Nutr. Soc.* **64**, 527–542 (2005).

6. Rayman, M. P. Selenium and human health. *Lancet* **379**, 1256–1268 (2012).

7. Duffield-Lillico, A. J. *et al*. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. *J. Natl. Cancer Inst.* **95**, 1477–1481 (2003).

8. Stranges, S. *et al*. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. *Ann. Intern. Med.* **147**, 217–223 (2007).

9. Lippman, S. M. *et al*. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). *Jama* **301**, 39–51 (2009).

10. Weekley, C. M. & Harris, H. H. Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. *Chem. Soc. Rev.* **42**, 8870–8894 (2013).

11. Zorn, M., Ihling, C. H., Golbik, R., Sawers, R. G. & Sinz, A. Selective seIC-independent selenocysteine incorporation into formate dehydrogenases. *PloS one* **8**, e61913 (2013).

12. Bierla, K. *et al*. A comparative study of the Se/S substitution in methionine and cysteine in Se-enriched yeast using an inductively coupled plasma mass spectrometry (ICP MS)-assisted proteomics approach. *J. Proteomics* **87**, 26–39 (2013).
13. Jackson, M. I. & Combs, G. F. Jr. Selenium and anticarcinogenesis: underlying mechanisms. *Curr. Opin. Clin. Nutr. Metab. Care* **11**, 718–726 (2008).

14. Letavayova, L., Vlckova, V. & Brozmanova, J. Selenium: from cancer prevention to DNA damage. *Toxicology* **227**, 1–14 (2006).

15. Peyroche, G. *et al.* Sodium selenide toxicity is mediated by O₂-dependent DNA breaks. *PloS one* **7**, e36343 (2012).

16. Seitomer, E., Balar, B., He, D., Copeland, P. R. & Kinzy, T. G. Analysis of *Saccharomyces cerevisiae* null allele strains identifies a larger role for DNA damage versus oxidative stress pathways in growth inhibition by selenium. *Mol. Nutr. Food Res.* **52**, 1305–1315 (2008).

17. Manikova, D. *et al.* Selenium toxicity toward yeast as assessed by microarray analysis and deletion mutant library screen: a role for DNA repair. *Chem. Res. Toxicol.* **25**, 1598–1608 (2012).

18. Bockhorn, J. *et al.* Genome-wide screen of *Saccharomyces cerevisiae* null allele strains identifies genes involved in selenomethionine resistance. *Proc. Natl. Acad. Sci. USA* **105**, 17682–17687 (2008).

19. Lazard, M., Dauplais, M., Blanquet, S. & Plateau, P. Trans-sulfuration pathway seleno-amino acids are mediators of selenomethionine toxicity in *Saccharomyces cerevisiae*. *J. Biol. Chem.* **290**, 10741–10750 (2015).

20. Schuh, A. L. & Audhya, A. The ESCRT machinery: from the plasma membrane to endosomes and back again. *Crit. Rev. Biochem. Mol. Biol.* **49**, 242–261 (2014).

21. Vainberg, I. E. *et al.* Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. *Cell* **93**, 863–873 (1998).

22. Malkowski, M. G. *et al.* Blocking S-adenosylmethionine synthesis in yeast allows selenomethionine incorporation and multiwavelength anomalous dispersion phasing. *Proc. Natl. Acad. Sci. USA* **104**, 6678–6683 (2007).

23. Kitajima, T., Chiba, Y. & Jigami, Y. Mutation of high-affinity methionine permease contributes to selenomethionyl protein production in *Saccharomyces cerevisiae*. *Appl. Environ. Microbiol.* **76**, 6351–6359 (2010).

24. Glover, J. R. & Lindquist, S. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. *Cell* **94**, 73–82 (1998).

25. Steffen, K. K. *et al.* Ribosome deficiency protects against ER stress in *Saccharomyces cerevisiae*. *Genetics* **191**, 107–118 (2012).

26. dos Santos, S. C., Teixeira, M. C., Cabrito, T. R. & Sa-Correia, I. Yeast toxicogenomics: genome-wide responses to chemical stresses with impact in environmental health, pharmacology, and biotechnology. *Front. Genet.* **3**, 63 (2012).

27. dos Santos, S. C. & Sa-Correia, I. Yeast toxicogenomics: lessons from a eukaryotic cell model and cell factory. *Curr. Opin. Biotechnol.* **33**, 183–191 (2015).

28. Giaever, G. *et al.* Functional profiling of the *Saccharomyces cerevisiae* genome. *Nature* **418**, 387–391 (2002).

29. Hoepfner, D. *et al.* High-resolution chemical dissection of a model eukaryote reveals targets, pathways and gene functions. *Microbiol. Res.* **169**, 107–120 (2014).

30. Iorio, F. *et al.* Discovery of drug mode of action and drug repositioning from transcriptional responses. *Proc. Natl. Acad. Sci. USA* **107**, 14621–14626 (2010).

31. Lee, A. Y. *et al.* Mapping the cellular response to small molecules using chemogenomic fitness signatures. *Science* **344**, 208–211 (2014).

32. Wysocki, R. & Tamas, M. J. How *Saccharomyces cerevisiae* copes with toxic metals and metalloids. *Fems Microbiol. Rev.* **34**, 925–951 (2010).

33. Tamas, M. J., Sharma, S. K., Istedt, S., Jacobson, T. & Christen, P. Heavy metals and metalloids as a cause for protein misfolding and aggregation. *Biomolecules* **4**, 252–267 (2014).

34. Holland, S. *et al.* Application of the comprehensive set of heterozygous yeast deletion mutants to elucidate the molecular basis of cellular chromium toxicity. *Genome Biol.* **8**, R268 (2007).

35. Holland, S. L., Ghosh, E. & Avery, S. V. Chromate-induced sulfur starvation and mRNA mistranslation in yeast are linked in a common mechanism of Cr toxicity. *Toxicol. In Vitro* **24**, 1764–1767 (2010).

36. Navarro-Yepes, J. *et al.* Inhibition of protein ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium impairs ubiquitin-dependent protein degradation pathways. *Mol. Neurobiol.* **53**, 5229–5251 (2016).

37. Roe, S. M. *et al.* Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. *J. Med. Chem.* **42**, 260–266 (1999).

38. Travers, K. J. *et al.* Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. *Cell* **101**, 249–258 (2000).

39. Sherman, M. Y. & Qian, S. B. Less is more: improving proteostasis by translation slow down. *Trends Biochem. Sci.* **38**, 585–591 (2013).

40. Ouerdane, L. & Mester, Z. Production and characterization of fully selenomethionine-labeled *Saccharomyces cerevisiae*. *J. Agric. Food Chem.* **56**, 11792–11799 (2008).

41. Stadtman, E. R. & Levine, R. L. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. *Amino acids* **25**, 207–218 (2003).

42. Weids, A. J. & Grant, C. M. The yeast peroxiredoxin Tsa1 protects against protein-aggregate-induced oxidative stress. *J. Cell Sci.* **127**, 1327–1335 (2014).

43. Dunlop, R. A., Cox, P. A., Banack, S. A. & Rodgers, K. J. The non-protein amino acid BMAA is misincorporated into human proteins in place of L-serine causing protein misfolding and aggregation. *PloS one* **8**, e75376 (2013).

44. Scheper, G. C., van der Knaap, M. S. & Proud, C. G. Translation matters: protein synthesis defects in inherited disease. *Nat. Rev. Genet.* **8**, 711–723 (2007).

45. Lee, J. W. *et al.* Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. *Nature* **443**, 50–55 (2006).

46. Van Hoewyk, D. A tale of two toxicities: malformed selenoproteins and oxidative stress both contribute to selenium stress in plants. *Ann. Bot.* **112**, 965–972 (2013).

47. Neuhierl, B. & Bock, A. On the mechanism of selenium tolerance in selenium-accumulating plants. Purification and characterization of a specific selenocysteine methyltransferase from cultured cells of *Astragalus bisculatus*. *Eur. J. Biochem.* **239**, 235–238 (1996).

48. Ellis, D. R. *et al.* Production of Se-methylselenocysteine in transgenic plants expressing selenocysteine methyltransferase. *BMC Plant Biol.* **4**, 1 (2004).

49. LeDuc, D. L. *et al.* Overexpression of selenocysteine methyltransferase in *Arabidopsis* and Indian mustard increases selenium tolerance and accumulation. *Plant Physiol.* **135**, 377–383 (2004).

50. Dimkovikj, A., Fisher, B., Hutchison, K. & Van Hoewyk, D. Stuck between a ROS and a hard place: Analysis of the ubiquitin proteasome pathway in selenocysteine treated *Brassica napus* reveals different toxicities during selenium assimilation. *J. Plant Physiol.* **181**, 50–54 (2015).

51. Wallenberg, M. *et al.* Selenium induces a multi-targeted cell death process in addition to ROS formation. *J. Cell. Mol. Med.* **18**, 671–684 (2014).

52. Hatfield, D. L. & Gladyshev, V. N. The outcome of selenium and vitamin E cancer prevention trial (SELECT) reveals the need for better understanding of selenium biology. *Mol. Interv.* **9**, 18–21 (2009).

53. Decourty, L. *et al.* Long open reading frame transcripts escape nonsense-mediated mRNA decay in yeast. *Cell Rep.* **6**, 593–598 (2014).

54. Malabat, C. & Saveanu, C. Identification of links between cellular pathways by Genetic Interaction Mapping (GIM). *Methods Mol. Biol.* **1361**, 325–343 (2016).

55. Eyboulet, F. *et al.* Mediator independently orchestrates multiple steps of preinitiation complex assembly *in vivo*. *Nucleic Acids Res.* **43**, 9214–9231 (2015).
**Acknowledgements**

The authors thank Marie-Claire Schanne-Klein for permission to use the ZEISS Axio Observer fluorescence microscope. This work has benefited from the facilities and expertise of the SICaPS platform of I2BC. (http://www.i2bc.paris-saclay.fr).

**Author Contributions**

M.L., P.P., C.S. and S.B. designed research; M.L., P.P., C.S., R.L., M.D. and L.D performed research; Data Curation C.S.; M.L. and P.P. wrote the original draft; M.L., P.P., C.S., M.D., A.J. and S.B. reviewed and edited the manuscript.

**Additional Information**

**Accession codes:** The raw microarray data has been deposited in the NCBI GEO database under accession n° GSE84340.

**Supplementary information** accompanies this paper at http://www.nature.com/srep

**Competing Interests:** The authors declare no competing financial interests.

**How to cite this article:** Plateau, P. et al. Exposure to selenomethionine causes selenocysteine misincorporation and protein aggregation in *Saccharomyces cerevisiae*. *Sci. Rep.* 7, 44761; doi: 10.1038/srep44761 (2017).

**Publisher's note:** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

<figure><img src="image_12.png" /></figure>

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

© The Author(s) 2017